Indobufen
Showing 1 - 10 of 10
Ischemic Stroke, Indobufen, Aspirin Trial (Indobufen, Aspirin)
Completed
- Ischemic Stroke
- +2 more
- Indobufen
- Aspirin
-
Beijing, Beijing, ChinaBeijing Tian Tan Hospital, Capital Medical University
Jan 5, 2023
Coronary Atherosclerosis Trial in Nanjing (aspirin 100 mg/d, indobufen 200 mg bid)
Recruiting
- Coronary Atherosclerosis
- aspirin 100 mg/d
- indobufen 200 mg bid
-
Nanjing, Jiangsu, ChinaFirst Affiliated Hospital of Nanjing Medical University
Jan 18, 2022
Coronary Artery Disease, Gastroesophageal Reflux Disease Trial in Beijing (Indobufen and aspirin mimetic, Aspirin and indobufen
Unknown status
- Coronary Artery Disease
- Gastroesophageal Reflux Disease
- Indobufen and aspirin mimetic
- Aspirin and indobufen mimetic
-
Beijing, ChinaBeijing Anzhen Hospital, Capital Medical University
Oct 14, 2019
Ticagrelor in Elderly Patients Undergoing Percutaneous Coronary
Completed
- Platelet Aggregation Inhibitors
- +3 more
-
Dalian, ChinaThe First Affiliated Hospital of Dalian Medical University
Aug 5, 2021
Coronary Atherosclerosis Trial in Nanjing (aspirin 100mg/d therapy, aspirin 100mg/2d therapy, aspirin 100mg/3d therapy)
Unknown status
- Coronary Atherosclerosis
- aspirin 100mg/d therapy
- +6 more
-
Nanjing, Jiangsu, ChinaFirst Affiliated Hospital of Nanjing Medical University
Jul 27, 2017
Healthy Trial in Pusan, Seoul (Indobufen)
Unknown status
- Healthy
- Indobufen
-
Pusan, Korea, Republic of
- +1 more
Nov 9, 2010
Intermittent Claudication Trial in Perugia (NCX-4016, NCX4016 )
Completed
- Intermittent Claudication
- NCX-4016
- NCX4016 placebo
-
Perugia, ItalyOspedale di Perugia
Jan 18, 2011